INVESTIGATING THE ROLE OF INFLAMMATORY BIOMARKERS IN THE PROGRESSION AND PROGNOSIS OF CHRONIC METABOLIC DISORDERS

Abstract

Chronic low-grade inflammation has emerged as a fundamental mechanism underlying metabolic dysfunction, insulin resistance, and the progression of complex metabolic diseases. This study employed an experimental mixed-method approach to quantitatively and qualitatively characterize immunometabolic performance across graded metabolic states. Comparative analyses revealed marked heterogeneity in inflammatory burden, insulin signaling efficiency, oxidative stress indices, and immune–metabolic coupling parameters. Performance comparison tables demonstrated nonlinear amplification of pro-inflammatory cytokines, progressive deterioration of insulin sensitivity metrics, and significant modulation of macrophage polarization and lipid–inflammation interaction coefficients with increasing metabolic stress. Graphical visualizations further illustrated temporal oscillations in inflammatory signaling, inverse associations between insulin sensitivity and inflammatory load, proportional dominance of specific immune pathways, and multidimensional interaction landscapes integrating metabolic and immune variables. Three-dimensional representations highlighted the convergence of inflammation, metabolic dysregulation, and cellular stress within a unified immunometabolic space. Together, the results confirm that metaflammation represents a sustained, systemic process rather than an acute inflammatory response, driving metabolic imbalance through coordinated endocrine, paracrine, and cellular stress pathways. These findings emphasize the value of integrated inflammatory–metabolic indices as robust biomarkers and support the targeting of immune–metabolic crosstalk as a strategic avenue for the prevention and management of metabolic diseases.